Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for ANTI-FGFR2 ANTIKÖRPER IN KOMBINATION MIT CHEMOTHERAPEUTISCHEN MITTELN ZUR BEHANDLUNG VON KREBS
Details for 2018730518
Up to date per 14.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018730518
Title / Product Name
ANTI-FGFR2 ANTIKÖRPER IN KOMBINATION MIT CHEMOTHERAPEUTISCHEN MITTELN ZUR BEHANDLUNG VON KREBS
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2018730518
EP Publication Number
3624837
E-Number
1818220
Language
EN
PCT Number
US18032757
Publication Date
25.03.2020 A
30.07.2025 B1
Registration Date
30.07.2025
AT Publication Date
15.08.2025
Application Date
15.05.2018
Registration Number
-
Priorities
16.05.2017
US
201762507053 P
06.11.2017
US
201762581992 P
IPC
A61K 39/00 20060101AFI20181123BHEP
Maximum Duration of Protection
15.05.2038
Owner
Five Prime Therapeutics, Inc.
111 Oyster Point Boulevard
South San Francisco, CA 94080
US
Representative
No representatives present
Inventor
COLLINS, Helen L.
111 Oyster Point Boulevard
South San Francisco California 94080
US
HNATYSZYN, James
111 Oyster Point Boulevard
South San Francisco California 94080
US
XIANG, Hong
111 Oyster Point Boulevard
South San Francisco California 94080
US
ZHANG, Xiang
111 Oyster Point Boulevard
South San Francisco California 94080
US
Information about Fees
Click here to load the fees